154 related articles for article (PubMed ID: 9510043)
1. Relationship between potential doubling time (Tpot), labeling index and duration of DNA synthesis in 60 esophageal and 35 breast tumors: Is it worthwhile to measure Tpot?
Haustermans K; Fowler J; Geboes K; Christiaens MR; Lerut A; van der Schueren E
Radiother Oncol; 1998 Feb; 46(2):157-67. PubMed ID: 9510043
[TBL] [Abstract][Full Text] [Related]
2. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
Tsang RW; Fyles AW; Kirkbride P; Levin W; Manchul LA; Milosevic MF; Rawlings GA; Banerjee D; Pintilie M; Wilson GD
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1319-29. PubMed ID: 7635771
[TBL] [Abstract][Full Text] [Related]
3. Do cell kinetics have prognostic and/or predictive value in oesophageal cancer treated by surgery?
Haustermans K; Fowler F; Geboes K; Lerut T; van der Schueren E
Eur J Surg Oncol; 1997 Aug; 23(4):293-7. PubMed ID: 9315055
[TBL] [Abstract][Full Text] [Related]
4. Intra-tumoral heterogeneity of tumour potential doubling times (Tpot) in colorectal cancer.
Wilson MS; West CM; Wilson GD; Roberts SA; James RD; Schofield PF
Br J Cancer; 1993 Sep; 68(3):501-6. PubMed ID: 8353040
[TBL] [Abstract][Full Text] [Related]
5. Is there a future for cell kinetic measurements using IdUrd or BdUrd?
Haustermans K; Fowler JF
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):505-11. PubMed ID: 11173147
[TBL] [Abstract][Full Text] [Related]
6. Cell kinetic measurements in prostate cancer.
Haustermans KM; Hofland I; Van Poppel H; Oyen R; Van de Voorde W; Begg AC; Fowler JF
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1067-70. PubMed ID: 9169814
[TBL] [Abstract][Full Text] [Related]
7. Cellular kinetics in rectal cancer.
Terry NH; Meistrich ML; Roubein LD; Lynch PM; Dubrow RA; Rich TA
Br J Cancer; 1995 Aug; 72(2):435-41. PubMed ID: 7640229
[TBL] [Abstract][Full Text] [Related]
8. Effects of tamoxifen on potential doubling time of human breast cancer cell line determined by image cytometry of double fluorescent BrdU and DNA labeling.
Rostagno P; Moll JL; Birtwisle-Peyrottes I; Ettore F; Lagrange JL; Gioanni J; Caldani C
Anticancer Res; 1994; 14(5A):2025-32. PubMed ID: 7531416
[TBL] [Abstract][Full Text] [Related]
9. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].
Margarino G; Scala M; Schenone G; Mereu P; Corvo R; Sanguineti G; Giaretti W; Geido E; Orecchia R; Meszaros P
Acta Otorhinolaryngol Ital; 1992; 12(5):421-33. PubMed ID: 1303006
[TBL] [Abstract][Full Text] [Related]
10. Proliferative characteristics of head and neck tumors. In vivo evaluation by bromodeoxyuridine incorporation and flow cytometry.
Benazzo M; Mevio E; Occhini A; Franchini G; Danova M
ORL J Otorhinolaryngol Relat Spec; 1995; 57(1):39-43. PubMed ID: 7700609
[TBL] [Abstract][Full Text] [Related]
11. Interrelationships of DNA-ploidy and cell proliferation markers with T-stage and N-stage in primary laryngeal tumors.
Struikmans H; Rutgers DH; Hordijk GJ; Slootweg PJ; van der Tweel I; Battermann JJ
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):303-8. PubMed ID: 9457813
[TBL] [Abstract][Full Text] [Related]
12. Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables.
Tsang RW; Fyles AW; Li Y; Rajaraman MM; Chapman W; Pintilie M; Wong CS
Radiother Oncol; 1999 Jan; 50(1):85-92. PubMed ID: 10225561
[TBL] [Abstract][Full Text] [Related]
13. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.
Begg AC; Haustermans K; Hart AA; Dische S; Saunders M; Zackrisson B; Gustaffson H; Coucke P; Paschoud N; Hoyer M; Overgaard J; Antognoni P; Richetti A; Bourhis J; Bartelink H; Horiot JC; Corvo R; Giaretti W; Awwad H; Shouman T; Jouffroy T; Maciorowski Z; Dobrowsky W; Struikmans H; Wilson GD
Radiother Oncol; 1999 Jan; 50(1):13-23. PubMed ID: 10225552
[TBL] [Abstract][Full Text] [Related]
14. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks.
Bourhis J; Dendale R; Hill C; Bosq J; Janot F; Attal P; Fortin A; Marandas P; Schwaab G; Wibault P; Malaise EP; Bobin S; Luboinski B; Eschwege F; Wilson G
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):471-6. PubMed ID: 8655369
[TBL] [Abstract][Full Text] [Related]
15. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Barra S; Margarino G; Bacigalupo A; Vitale V
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1165-72. PubMed ID: 8262843
[TBL] [Abstract][Full Text] [Related]
16. Influence of sampling time on assessment of potential doubling time.
Høyer M; Bentzen SM; Salling LN; Overgaard J
Cytometry; 1994 Jun; 16(2):144-51. PubMed ID: 7924683
[TBL] [Abstract][Full Text] [Related]
17. In vivo cell kinetic measurements in human oesophageal cancer: what can be learned from multiple biopsies?
Haustermans K; Vanuytsel L; Geboes K; Lerut T; Van Thillo J; Leysen J; Coosemans W; van der Schueren E
Eur J Cancer; 1994; 30A(12):1787-91. PubMed ID: 7880607
[TBL] [Abstract][Full Text] [Related]
18. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations.
Begg AC; Moonen L; Hofland I; Dessing M; Bartelink H
Radiother Oncol; 1988 Apr; 11(4):337-47. PubMed ID: 3375460
[TBL] [Abstract][Full Text] [Related]
19. Tumour kinetics in breast cancer.
Winters Z; Mohube P; Gray C; Wright C; Teare J; Lange M; Mannell A; Myburgh JA
S Afr J Surg; 1994 Dec; 32(4):135-40. PubMed ID: 7597509
[TBL] [Abstract][Full Text] [Related]
20. Comparison of flow and laser scanning cytometry for the assay of cell proliferation in human solid tumors.
Rew DA; Reeve LJ; Wilson GD
Cytometry; 1998 Nov; 33(3):355-61. PubMed ID: 9822347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
